Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | 11.76 |
peg ratio | 0.28 |
price to book ratio | 1.96 |
price to sales ratio | 5.90 |
enterprise value multiple | 3.12 |
price fair value | 1.96 |
profitability ratios | |
---|---|
gross profit margin | 70.53% |
operating profit margin | 68.14% |
pretax profit margin | 75.66% |
net profit margin | 50.54% |
return on assets | 6.35% |
return on equity | 17.37% |
return on capital employed | 9.15% |
liquidity ratio | |
---|---|
current ratio | 1.54 |
quick ratio | 1.54 |
cash ratio | 0.81 |
efficiency ratio | |
---|---|
days of inventory outstanding | 0.00 |
operating cycle | 4.01 |
days of payables outstanding | 12.06 |
cash conversion cycle | -8.04 |
receivables turnover | 91.00 |
payables turnover | 30.28 |
inventory turnover | 0.00 |
debt and solvency ratios | |
---|---|
debt ratio | 0.42 |
debt equity ratio | 1.11 |
long term debt to capitalization | 0.49 |
total debt to capitalization | 0.53 |
interest coverage | 7.47 |
cash flow to debt ratio | 0.37 |
cash flow ratios | |
---|---|
free cash flow per share | 4.02 |
cash per share | 2.23 |
operating cash flow per share | 6.28 |
free cash flow operating cash flow ratio | 0.64 |
cash flow coverage ratios | 0.37 |
short term coverage ratios | 2.82 |
capital expenditure coverage ratio | 2.81 |
Frequently Asked Questions
Royalty Pharma plc (RPRX) published its most recent earnings results on 06-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Royalty Pharma plc (NASDAQ:RPRX)'s trailing twelve months ROE is 17.37%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Royalty Pharma plc (RPRX) currently has a ROA of 6.35%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
RPRX reported a profit margin of 50.54% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.54 in the most recent quarter. The quick ratio stood at 1.54, with a Debt/Eq ratio of 1.11.